Trial
NCT04473924
Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
—
Condition
Infection
Intervention
Mycophenolate Mofetil
Why stopped
Study has never started as sponsor did not approve for funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-06